1. BioXcel Therapeutics, Inc. (NASDAQ:BTAI)
Price Target Upside: 1,076.47%
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) is one of the best 52-week low stocks.
TheFly reported on April 2 that H.C. Wainwright lowered its price target on BTAI to $5 from $6 while maintaining a Buy rating. The firm attributed the revision to concerns over recent and expected equity dilution, which influenced its updated valuation outlook.
Separately, on April 8, BioXcel Therapeutics, Inc. (NASDAQ:BTAI) announced that it has begun enrolling the first patients in a U.S. Department of War-funded Phase 2a clinical study evaluating BXCL501 for acute stress reactions. The trial is being conducted in collaboration with the University of North Carolina at Chapel Hill Institute of Trauma Recovery and is designed as a randomized, placebo-controlled study enrolling around 100 participants who experience trauma-related acute stress, such as after motor vehicle accidents.
The research will assess whether BXCL501 can reduce symptom severity, improve cognitive functioning, and help prevent progression to longer-term neuropsychiatric conditions like post-traumatic stress disorder. The medication is being supplied by the company for the study. Acute stress reactions are common in both civilian and military populations and represent a large unmet medical need. The trial represents a key step in expanding clinical research for BXCL501 in trauma-related psychiatric indications and advancing potential pharmacological treatment options.
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) is a clinical-stage biopharmaceutical company that uses artificial intelligence to identify and develop new therapies. It focuses on neuroscience and immuno-oncology, advancing treatments for conditions such as agitation, schizophrenia, and cancer.
While we acknowledge the risk and potential of BTAI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BTAI and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Mid Cap Stocks to Invest In According to Billionaires and 10 Best Cheap Stocks Under $10 to Buy in April.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
